Because our results revealed that MA-35 exerts both anti-TNF-α and anti-TGF-β1 effects following the reduction of ECM production, we next investigated the anti-fibrotic effect of MA-35 in a renal fibrosis mice model, unilateral ureteral obstruction (UUO)17. Here, TNF is linked to Ureteral obstruction.